[NBIX] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
31-Oct-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -12.98%
YoY- 21.31%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 622,100 498,800 387,900 296,000 258,500 222,094 151,757 26.48%
PBT 190,300 115,600 97,900 30,500 -57,100 58,407 50,764 24.61%
Tax 60,500 32,500 29,400 8,000 500 4,618 7,672 41.03%
NP 129,800 83,100 68,500 22,500 -57,600 53,789 50,764 16.92%
Tax Rate -31.79% -28.11% -30.03% -26.23% - -7.91% -15.11% -
Total Cost 492,300 415,700 319,400 273,500 316,100 168,305 100,993 30.18%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 20.86 16.66 17.66 7.60 -22.28 24.22 33.45 -7.56%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS 1.28 0.85 0.72 0.24 -0.62 0.59 0.56 14.75%
EPS Diluted 1.24 0.82 0.69 0.23 -0.62 0.56 0.52 15.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.